[1]
Shrestha, S.B., Bhusal, M., Jwarchan, J., Gautam, S. and Shrestha, P.R. 2023. Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients. Journal of Nepal Health Research Council. 20, 4 (Jul. 2023), 881-885. DOI:https://doi.org/10.33314/jnhrc.v20i4.4233.